Atlas Trials

Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease

Clinical trial NCT02097056 · COMPLETED

Trial details

NCT number
NCT02097056
Sponsor
Eisai Korea Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2014-02-01
Primary completion
2015-05-01
Enrollment
171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.